Amphastar Pharmaceuticals, Inc. (AMPH) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 47.84M | 32.86M | 52.58M | 35.59M | 35.08M | 29.02M | 59.96M | 69.11M | 55.29M | 23.86M | 64.33M | 54.92M |
| Operating CF Margin % | 27.95% | 17.95% | 27.41% | 20.41% | 20.57% | 15.56% | 31.76% | 37.89% | 32.18% | 13.4% | 35.63% | 37.69% |
| Operating CF Growth % | 36.39% | 13.23% | -12.31% | -48.5% | -36.56% | 21.62% | -6.8% | 25.83% | 36.92% | 56.73% | 215.75% | 1851.08% |
| Net Income | 6.42M | 24.43M | 17.35M | 31.03M | 25.29M | 37.96M | 40.43M | 37.95M | 43.18M | 36.17M | 49.22M | 26.12M |
| Depreciation & Amortization | 14.35M | 15.99M | 14.13M | 13.02M | 15.21M | 14.66M | -4.11M | 14.14M | 13.96M | 13.79M | 13.57M | 7.02M |
| Stock-Based Compensation | 9.27M | 6.21M | 6.3M | 6.38M | 8.39M | 5.63M | 5.6M | 5.78M | 7.36M | 4.62M | 4.64M | 4.87M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.58M | -2.6M | 11.49M |
| Other Non-Cash Items | 2.49M | 28.97M | 2.81M | 3.69M | 2.91M | -20.65M | 25.37M | 2.6M | -1.94M | 8.61M | 5.24M | -3M |
| Working Capital Changes | 15.3M | -42.73M | 12M | -18.52M | -16.71M | -8.59M | -7.33M | 8.63M | -7.26M | -26.75M | -5.74M | 8.42M |
| Change in Receivables | -4.55M | 3.23M | -13.79M | 12.27M | -8.07M | 2.91M | -8.05M | 6.68M | -23.2M | 4.09M | -19.64M | 1.26M |
| Change in Inventory | 6.25M | 9.01M | 5.86M | -4.82M | -31.11M | -24.47M | -7.31M | -7.03M | -9.99M | 4.81M | -5.77M | -1.03M |
| Change in Payables | 9.6M | -42.64M | 25.34M | -4.86M | 17.61M | 2.11M | 24.65M | 13.72M | 23.08M | -3.39M | 6.45M | 2.68M |
| Cash from Investing | -16.73M | -60.57M | -19.62M | -625K | 10.48M | -35.68M | -34.59M | -69.9M | 15.24M | -103.05M | -31.15M | -508.58M |
| Capital Expenditures | -9.51M | -8.27M | -5.35M | -10.56M | -10.7M | -12.41M | -13.79M | -6.04M | -8.79M | -9.44M | -10.19M | -9.05M |
| CapEx % of Revenue | 5.55% | 4.52% | 2.79% | 6.06% | 6.27% | 6.65% | 7.3% | 3.31% | 5.12% | 5.3% | 5.65% | 6.21% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 129M | -129M | 0 | 506.41M | -5.58M | -500.83M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 67K | -434K | -1.59M | -4.58M | 0 | -1.47M | -129.1M | -1.6M | -960K | -508.08M | 4M | -586K |
| Cash from Financing | -30.21M | -18.37M | -4.35M | -30.2M | -14.5M | -33.84M | -22.82M | -10.72M | -13.58M | -47.08M | 86.61M | 428.11M |
| Debt Issued (Net) | -29K | -5.57M | 124K | 3.84M | 1.6M | 4.75M | 9.47M | -8.03M | 3.98M | -50.15M | 144.93M | 432.54M |
| Equity Issued (Net) | -29.49M | -18.53M | 49.73M | -38.73M | -11M | -42M | -34.96M | -2.68M | -17.31M | 3.56M | -50M | 9.72M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -29.49M | -20.52M | 50.22M | -39.22M | -11M | -42M | -34.96M | -8.5M | -17.31M | 0 | -50M | -128K |
| Other Financing | -686K | 5.73M | -54.2M | 4.68M | -5.11M | 3.41M | 2.67M | 1K | -252K | -491K | -8.31M | -14.15M |
| Net Change in Cash | 762K | -46.09M | 28.58M | 4.91M | 31.17M | -40.51M | 2.5M | -11.53M | 56.85M | -126.51M | 119.76M | -25.57M |
| Free Cash Flow | 38.33M | 24.59M | 47.23M | 25.03M | 24.38M | 16.61M | 46.17M | 63.06M | 46.5M | 14.42M | 54.14M | 45.87M |
| FCF Margin % | 22.39% | 13.43% | 24.62% | 14.35% | 14.3% | 8.91% | 24.45% | 34.58% | 27.06% | 8.1% | 29.99% | 31.48% |
| FCF Growth % | 57.23% | 48.02% | 2.31% | -60.32% | -47.57% | 15.19% | -14.72% | 37.49% | 50.45% | 61.75% | 267.01% | 1557.55% |
| FCF per Share | 0.83 | 0.52 | 0.99 | 0.52 | 0.49 | 0.32 | 0.89 | 1.21 | 0.88 | 0.27 | 1.00 | 0.86 |
| FCF Conversion (FCF/Net Income) | 7.45x | 1.35x | 3.03x | 1.15x | 1.39x | 0.76x | 1.48x | 1.82x | 1.28x | 0.66x | 1.31x | 2.10x |
| Interest Paid | 0 | 4.08M | 7.46M | 4.09M | 7.58M | 4.42M | 8.53M | 5.23M | 8.63M | 5.47M | 9.33M | 1.53M |
| Taxes Paid | 0 | 402K | 10K | 21.4M | 902K | -29M | 12.07M | 16.58M | 349K | 46.87M | 814K | 986K |